[1]
F. J. R. Paumgartten, “ Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda ”, Rev. saúde pública, vol. 50, p. 70, Jan. 2016, doi: 10.1590/s1518-8787.2016050006508.